CLINICAL ROLE -
Hepatitis C Combinations Show Similar Efficacy Profiles in Genotypes 2, 3
Treatment regimens consisting of daclatasvir plus sofosbuvir plus ribavirin and velpatasvir/sofosbuvir plus ribavirin show similar cure rates in patients with hepatitis C virus genotype 2 and 3.
VA Data Could Prove Key in Assessing Real-World Efficacy of Hepatitis C Drugs
The national Veterans Health Administration Corporate Data Warehouse could be key in revealing accurate data on the use of direct-acting antivirals in the treatment of chronic hepatitis C virus.
Sofosbuvir Achieves Sustained Virologic Response in HCV Patients With Cirrhosis
Study establishes real-world efficacy, tolerability, and safety profile of sofosbuvir-based regimens in patients with chronic hepatitis C who have compensated liver cirrhosis.
Respiratory Syncytial Virus Testing Not Common Among Pregnant Women
Testing for respiratory syncytial virus (RSV) infection during the influenza season is uncommon among pregnant mothers.
Trial Shows Non-Inferiority Between HIV Treatment Regimens
Tenofovir alafenamide plus emtricitabine can be safely used as an alternative to abacavir plus lamivudine in patients with HIV.
Female Hormones Shown to Reduce HIV Replication
Exposure to high levels of estrogen and progesterone may help curb proinflammatory cytokine and chemokine expression associated with HIV-1.
Cancer Survivorship Services Need Improvement
Identifying current deficiencies in clinical practice can help pinpoint care practices that can be implemented for cancer survivors.
2 Clarke Drive Cranbury, NJ 08512